CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell diseaseSelami Demirci, John F. Tisdale, Khaled Essawi et al.|Molecular Therapy — Methods & Clinical Development|2021Cited by 46
Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiationSelami Demirci, Naoya Uchida, Juan J. Haro‐Mora et al.|Stem Cell Research & Therapy|2020Cited by 42